Brief practical guidelines for biologic prescriptions in severe asthma. Expert opinion
Abstract
This brief paper is intended to be a quick guide to prescribe biologics in severe asthma by following Global Initiative for Asthma (GINA) guidelines but also considering the author’s personal opinions. The paper starts with the identification of candidates for biologic therapy examining next the biological markers to be taken into account for the phenotyping of inflammation. Finally, it indicates the type of biologic to be chosen. This guide also points out the possible signals that can allow us to identify patients with severe asthma that would otherwise be ignored. Furthermore, it tries to give some directions on how to proceed in order to select the right biologic in the cases where the overlapping of different phenotypes can be found or in non-T2 asthma.
Licenza
Questo lavoro è fornito con la licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 4.0 Internazionale.
Copyright
© Associazione Italiana Pneumologi Ospedalieri – Italian Thoracic Society (AIPO – ITS) , 2024
Come citare
- Abstract visualizzazioni - 111 volte
- PDF downloaded - 52 volte